Stock Fundamentals

Company Information

▼
Company Name
Revolution Medicines Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US76155X1000
CIK: 0001628171
CUSIP: 76155X100
Currency: USD
Full Time Employees: 809
Phone: 650 481 6801
Website: https://www.revmed.com
Fiscal Year End: December
IPO Date: Feb 13, 2020
Description:

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Address:

700 Saginaw Drive, Redwood City, CA, United States, 94063

Directors & Officers

▼
Name Title Year Born
Dr. Mark A. Goldsmith M.D., Ph.D. CEO, President & Chairman 1962
Mr. Jack Anders Chief Financial Officer 1977
Ms. Margaret A. Horn J.D. Chief Operating Officer 1963
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D. President of Research & Development 1961
Ms. Xiaolin Wang Executive Vice President of Development 1970
Dr. Martin D. Burke M.D., Ph.D. Co-Founder & Chairman of Scientific Advisory Board NA
Dr. Michael A. Fischbach Ph.D. Academic Co-Founder & Member of Scientific Advisory Board 1981
Dr. Kevan M. Shokat Ph.D. Academic Co-Founder & Member of Scientific Advisory Board NA
Mr. Walter Reiher Ph.D. Chief Information Officer NA
Ms. Jan Smith Ph.D. Chief Scientific Officer NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 16.72M Dec 31, 2025 8.44% $0.02 6.75%
Farallon Capital Management, L.L.C. 14.58M Dec 31, 2025 7.36% $5.48 -0.29%
HHG PLC 11.36M Sep 30, 2025 5.73% $0.24 7.23%
Baker Bros Advisors LP 9.46M Dec 31, 2025 4.77% $4.41 0.00%
FMR Inc 8.59M Dec 31, 2025 4.33% $0.03 -8.65%
BlackRock Inc 8.33M Sep 30, 2025 4.20% $0.01 -3.85%
Nextech Invest, Ltd. 7.60M Dec 31, 2025 3.84% $58.53 0.00%
Wellington Management Company LLP 6.99M Dec 31, 2025 3.53% $0.10 -28.80%
Paradigm Biocapital Advisors LP 6.64M Dec 31, 2025 3.35% $13.51 6.77%
State Street Corp 5.25M Sep 30, 2025 2.65% $0.01 11.35%
Bellevue Group AG 5.01M Dec 31, 2025 2.53% $7.56 -10.19%
JPMorgan Chase & Co 5.00M Sep 30, 2025 2.52% $0.01 76.11%
T. Rowe Price Investment Management,Inc. 4.78M Sep 30, 2025 2.41% $0.14 1.98%
Alphabet Inc 4.13M Sep 30, 2025 2.09% $8.01 0.00%
T. Rowe Price Associates, Inc. 3.87M Sep 30, 2025 1.95% $0.02 -17.62%
Bvf Inc 3.36M Dec 31, 2025 1.69% $9.00 -15.55%
Geode Capital Management, LLC 3.15M Sep 30, 2025 1.59% $0.01 5.07%
Deerfield Management Co 2.89M Dec 31, 2025 1.46% $2.94 -20.70%
Westfield Capital Management Company, L.P. 2.85M Dec 31, 2025 1.44% $0.94 13.17%
General Atlantic Llc 2.81M Dec 31, 2025 1.42% $7.80 13.68%

Shares Statistics

▼
Shares Outstanding: 193.32M
Shares Float: 174.04M
% Insiders: 203.90%
% Institutions: 10,491.70%
Short % Float: 7.18%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Group Inc 16.72M 8.44% ▲ 6.75% Dec 31, 2025
2 Farallon Capital Management, L.L.C. 14.58M 7.36% ▼ 0.29% Dec 31, 2025
3 HHG PLC 11.36M 5.73% ▲ 7.23% Sep 30, 2025
4 Baker Bros Advisors LP 9.46M 4.77% ▲ 0.00% Dec 31, 2025
5 FMR Inc 8.59M 4.33% ▼ 8.65% Dec 31, 2025
6 BlackRock Inc 8.33M 4.20% ▼ 3.85% Sep 30, 2025
7 Nextech Invest, Ltd. 7.60M 3.84% ▲ 0.00% Dec 31, 2025
8 Wellington Management Company LLP 6.99M 3.53% ▼ 28.80% Dec 31, 2025
9 Paradigm Biocapital Advisors LP 6.64M 3.35% ▲ 6.77% Dec 31, 2025
10 State Street Corp 5.25M 2.65% ▲ 11.35% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $17.96B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $19.72B
EBITDA: $-1.03B
Book Value: $8.42
Earnings/Share: $-5.19
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -32.29%
ROE (TTM): -60.76%
Revenue (TTM): $742.00K
Revenue/Share (TTM): $0.01
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -95.20%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 7.14x 0.01x 0.31x -48.80x -0.02x
2024-12-31 14.20x 0.01x 0.11x N/A -0.02x
2023-12-31 13.06x 0.00x 0.11x -1,607.87x -0.02x
2022-12-31 10.65x 0.01x 0.16x -26.75x -0.03x
2021-12-31 9.77x 0.01x 0.18x -15,667.33x -0.03x
2020-12-31 9.63x 0.01x 0.16x -1,559.11x -0.04x
2019-12-31 3.11x 0.00x 0.31x -510.57x 0.00x
2018-12-31 2.80x 0.00x 0.43x -347.66x 0.00x
2017-12-31 1.24x 0.00x 0.70x -302.22x 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 07, 2026 Margaret A Horn N/A Sale 75.00K $100.56 $7.54M
Jan 07, 2026 Jack Anders N/A Sale 10.00K $98.00 $980.00K
Dec 16, 2025 Jack Anders N/A Sale 3.10K $77.09 $239.29K
Dec 16, 2025 Margaret A Horn N/A Sale 4.85K $76.82 $372.35K
Dec 16, 2025 Mark A Goldsmith N/A Sale 15.39K $76.82 $1.18M
Dec 16, 2025 Stephen Michael Kelsey N/A Sale 5.45K $76.82 $418.44K
Nov 25, 2025 Mark A Goldsmith N/A Sale 60.00K $75.08 $4.50M
Nov 18, 2025 Mark A Goldsmith N/A Sale 20.00K $70.38 $1.41M
Nov 12, 2025 Mark A Goldsmith N/A Sale 20.00K $65.07 $1.30M
Nov 07, 2025 Mark A Goldsmith N/A Sale 30.00K $60.31 $1.81M
Oct 13, 2025 Stephen Michael Kelsey N/A Sale 25.00K $48.54 $1.21M
Sep 16, 2025 Jack Anders N/A Sale 2.32K $45.82 $106.30K
Sep 16, 2025 Stephen Michael Kelsey N/A Sale 5.37K $45.82 $245.92K
Sep 16, 2025 Mark A Goldsmith N/A Sale 13.41K $45.82 $614.49K
Sep 16, 2025 Margaret A Horn N/A Sale 4.78K $45.82 $218.79K
Sep 16, 2025 Lin Wei N/A Sale 2.16K $45.82 $98.97K
Sep 15, 2025 Stephen Michael Kelsey N/A Sale 25.00K $45.97 $1.15M
Sep 11, 2025 Stephen Michael Kelsey N/A Sale 100.00K $44.08 $4.41M
Sep 03, 2025 Jack Anders N/A Sale 5.24K $40.17 $210.41K
Sep 02, 2025 Jack Anders N/A Sale 4.76K $40.02 $190.58K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RVMD.US!